1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid
1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid structure
|
Common Name | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid | ||
|---|---|---|---|---|
| CAS Number | 139755-99-0 | Molecular Weight | 168.19300 | |
| Density | 1.19g/cm3 | Boiling Point | 330.3ºC at 760mmHg | |
| Molecular Formula | C8H12N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 153.5ºC | |
| Name | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.19g/cm3 |
|---|---|
| Boiling Point | 330.3ºC at 760mmHg |
| Molecular Formula | C8H12N2O2 |
| Molecular Weight | 168.19300 |
| Flash Point | 153.5ºC |
| Exact Mass | 168.09000 |
| PSA | 55.12000 |
| LogP | 1.07080 |
| Vapour Pressure | 6.74E-05mmHg at 25°C |
| InChIKey | KOABFSONXOOIIH-UHFFFAOYSA-N |
| SMILES | CCCc1cc(C(=O)O)n(C)n1 |
| HS Code | 2933199090 |
|---|
|
~95%
1-Methyl-3-prop... CAS#:139755-99-0 |
| Literature: AUSPEX PHARMACEUTICALS, INC. Patent: US2008/194529 A1, 2008 ; Location in patent: Page/Page column 56-57 ; US 20080194529 A1 |
|
~54%
1-Methyl-3-prop... CAS#:139755-99-0
Learn More
|
| Literature: Journal of Heterocyclic Chemistry, , vol. 38, # 5 p. 1045 - 1050 |
|
~%
1-Methyl-3-prop... CAS#:139755-99-0 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 17 p. 3900 - 3907 |
|
~%
1-Methyl-3-prop... CAS#:139755-99-0 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 6, # 15 p. 1819 - 1824 |
|
~%
1-Methyl-3-prop... CAS#:139755-99-0 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 38, # 5 p. 1045 - 1050 |
| Precursor 5 | |
|---|---|
| DownStream 7 | |
CAS#:200575-15-1
CAS#:139756-01-7
CAS#:139756-03-9![5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone structure](https://image.chemsrc.com/caspic/311/139756-21-1.png)
CAS#:139756-21-1
CAS#:139756-02-8
CAS#:139756-00-6
CAS#:128537-50-8| HS Code | 2933199090 |
|---|---|
| Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|
|
Name: A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS979
|
|
Name: Cell-based high throughput primary assay to identify activators of GPR151
Source: The Scripps Research Institute Molecular Screening Center
Target: RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id: GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
Name: AlphaScreen-based biochemical high throughput primary assay to identify activators of...
Source: The Scripps Research Institute Molecular Screening Center
Target: N/A
External Id: FBW7_ACT_ALPHA_1536_1X%ACT PRUN
|
|
Name: AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
Source: The Scripps Research Institute Molecular Screening Center
External Id: MITF_INH_Alpha_1536_1X%INH PRUN
|
| 2-methyl-5-propylpyrazole-3-carboxylic acid |
| MFCD02169703 |
| Methisosildenafil Impurity 14 |